Published in Int J Cancer on July 21, 2012
Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. Trends Cell Biol (2015) 1.87
MiR-200, a new star miRNA in human cancer. Cancer Lett (2013) 1.50
Genomic landscape of cutaneous T cell lymphoma. Nat Genet (2015) 1.27
The Regulatory Role of MicroRNAs in EMT and Cancer. J Oncol (2015) 1.22
Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation. Proc Natl Acad Sci U S A (2013) 1.21
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis. Front Oncol (2015) 1.15
Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. Cancer Manag Res (2014) 1.13
The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory. Mol Cancer (2015) 1.08
Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells. J Virol (2013) 1.02
MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis. Carcinogenesis (2014) 1.02
The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma. Cell Death Differ (2013) 1.01
p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model. PLoS One (2013) 0.94
Homeoprotein Six2 promotes breast cancer metastasis via transcriptional and epigenetic control of E-cadherin expression. Cancer Res (2014) 0.94
MicroRNA-200 (miR-200) cluster regulation by achaete scute-like 2 (Ascl2): impact on the epithelial-mesenchymal transition in colon cancer cells. J Biol Chem (2014) 0.93
MicroRNA-200b suppresses arsenic-transformed cell migration by targeting protein kinase Cα and Wnt5b-protein kinase Cα positive feedback loop and inhibiting Rac1 activation. J Biol Chem (2014) 0.92
Functional Role of the microRNA-200 Family in Breast Morphogenesis and Neoplasia. Genes (Basel) (2014) 0.92
MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2. Oncotarget (2015) 0.92
Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo. Sci Rep (2013) 0.91
Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol Cancer (2016) 0.90
The impact of post-transcriptional regulation in the p53 network. Brief Funct Genomics (2012) 0.89
MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. Cell Commun Signal (2014) 0.86
Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer. Oncotarget (2015) 0.84
Noncoding RNA and colorectal cancer: its epigenetic role. J Hum Genet (2016) 0.84
ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres. Brain Pathol (2015) 0.83
Transcription regulation of E-cadherin by zinc finger E-box binding homeobox proteins in solid tumors. Biomed Res Int (2014) 0.83
FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer. Oncogene (2014) 0.82
Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation. J Clin Med (2016) 0.81
MicroRNA-200a suppresses metastatic potential of side population cells in human hepatocellular carcinoma by decreasing ZEB2. Oncotarget (2015) 0.81
Glioblastoma Circulating Cells: Reality, Trap or Illusion? Stem Cells Int (2015) 0.81
The role of miR-200a in mammalian epithelial cell transformation. Carcinogenesis (2014) 0.81
Non-coding landscapes of colorectal cancer. World J Gastroenterol (2015) 0.80
The network of pluripotency, epithelial-mesenchymal transition, and prognosis of breast cancer. Breast Cancer (Dove Med Press) (2015) 0.80
MicroRNA-mRNA interactions underlying colorectal cancer molecular subtypes. Nat Commun (2015) 0.80
MicroRNA Regulation of Epithelial to Mesenchymal Transition. J Clin Med (2016) 0.80
Sirtuins and Cancer: Role in the Epithelial-Mesenchymal Transition. Oxid Med Cell Longev (2016) 0.79
Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2. Mol Cell Biol (2016) 0.78
Resveratrol suppresses myofibroblast activity of human buccal mucosal fibroblasts through the epigenetic inhibition of ZEB1 expression. Oncotarget (2016) 0.78
High-throughput sequencing approach uncovers the miRNome of peritoneal endometriotic lesions and adjacent healthy tissues. PLoS One (2014) 0.78
miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition. Front Pharmacol (2016) 0.77
Combined microRNA and ER expression: a new classifier for familial and sporadic breast cancer patients. J Transl Med (2014) 0.77
MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation. IUBMB Life (2015) 0.77
Mathematical Modelling of Molecular Pathways Enabling Tumour Cell Invasion and Migration. PLoS Comput Biol (2015) 0.77
miR-8 modulates cytoskeletal regulators to influence cell survival and epithelial organization in Drosophila wings. Dev Biol (2016) 0.76
Mechanisms of polarity protein expression control. Curr Opin Cell Biol (2016) 0.76
The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer. Mol Oncol (2017) 0.76
A proposed method for the relative quantification of levels of circulating microRNAs in the plasma of gastric cancer patients. Oncol Lett (2017) 0.75
53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer. Cancer Sci (2015) 0.75
Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasis. Oncotarget (2016) 0.75
Colorectal cancer: Is the new era of colorectal cancer classification finally here? Nat Rev Gastroenterol Hepatol (2013) 0.75
The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia. Blood (2016) 0.75
High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells. BMC Genomics (2015) 0.75
Development of a circulating miRNA assay to monitor tumor burden: From mouse to man. Mol Oncol (2015) 0.75
Members of the microRNA-200 family are promising therapeutic targets in cancer. Exp Ther Med (2017) 0.75
SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res (2005) 3.41
Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr Biol (2002) 2.73
A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell (2013) 2.46
Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. Mol Biol Cell (2007) 1.71
SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer. Proc Natl Acad Sci U S A (2009) 1.56
Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene (2004) 1.44
Liprin beta 1, a member of the family of LAR transmembrane tyrosine phosphatase-interacting proteins, is a new target for the metastasis-associated protein S100A4 (Mts1). J Biol Chem (2001) 1.34
ZEB proteins link cell motility with cell cycle control and cell survival in cancer. Cell Cycle (2010) 1.23
Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells. Mol Cell Biol (2005) 1.15
Genetic and epigenetic alterations of the APC gene in malignant melanoma. Oncogene (2004) 1.05
The ability of Fos family members to produce phenotypic changes in epithelioid cells is not directly linked to their transactivation potentials. Oncogene (2002) 0.98
Reactive oxygen species and mitochondrial sensitivity to oxidative stress determine induction of cancer cell death by p21. J Biol Chem (2012) 0.98
Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility. Oncogene (2003) 0.94
Novel monoclonal antibodies detect Smad-interacting protein 1 (SIP1) in the cytoplasm of human cells from multiple tumor tissue arrays. Exp Mol Pathol (2010) 0.90
Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells. Int J Oncol (2009) 0.90
Skn-1a/Oct-11 and ΔNp63α exert antagonizing effects on human keratin expression. Biochem Biophys Res Commun (2010) 0.86
Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB. Oncotarget (2013) 0.79